# FAS

## Overview
The FAS gene encodes the Fas cell surface death receptor, a transmembrane protein that is a critical component of the tumor necrosis factor receptor (TNFR) superfamily. This receptor plays a pivotal role in the regulation of apoptosis, particularly within the immune system, by mediating programmed cell death upon interaction with its ligand, FasL (Fas ligand) (Strasser2009The). The Fas receptor is integral to maintaining immune homeostasis, as it facilitates the elimination of autoreactive lymphocytes and the resolution of immune responses post-infection, thereby preventing autoimmune disorders and excessive immune activation (Lynch1995Fas). The gene's expression is tightly regulated, with increased levels observed during T cell activation, which is essential for the differentiation and function of cytotoxic T lymphocytes (Alderson1993Fas). Mutations in the FAS gene are linked to autoimmune lymphoproliferative syndrome (ALPS), underscoring its clinical significance in immune regulation (Hsu2012Autoimmune).

## Structure


## Function
The FAS gene encodes the Fas cell surface death receptor, a critical component in the regulation of apoptosis, particularly within the immune system. Fas is a member of the tumor necrosis factor receptor (TNFR) superfamily and is primarily involved in inducing programmed cell death upon binding with its ligand, FasL (Fas ligand) (Strasser2009The). This interaction leads to the formation of a death-inducing signaling complex (DISC), which includes caspase-8 and FADD, initiating a cascade of intracellular signaling events that result in apoptosis (Strasser2009The).

In healthy human cells, Fas signaling is essential for maintaining immune homeostasis by eliminating autoreactive lymphocytes and terminating immune responses after infections. This process helps prevent autoimmune diseases and excessive immune activation (Lynch1995Fas). Fas is also involved in the activation and proliferation of T cells, providing a costimulatory signal that enhances T cell activation during the early stages of an immune response (Alderson1993Fas). The expression of Fas is highly regulated, with increased expression upon T cell activation, which is crucial for the differentiation of pre-cytotoxic T lymphocytes into functional cytotoxic T lymphocytes (Lynch1995Fas).

## Clinical Significance
Mutations in the FAS gene, which encodes the Fas cell surface death receptor, are primarily associated with autoimmune lymphoproliferative syndrome (ALPS). ALPS is characterized by defective lymphocyte apoptosis, leading to symptoms such as nonmalignant lymphadenopathy, splenomegaly, and an expansion of double-negative T cells. These mutations often result in impaired apoptosis due to dominant-negative interference or haploinsufficiency, where the reduced amount of functional FAS protein is insufficient for normal physiological function (Hsu2012Autoimmune; Price2014Natural).

Mutations can occur in various regions of the FAS gene, including the extracellular, transmembrane, and intracellular domains. Those affecting the death domain (DD) are particularly significant, as they often lead to defective receptor trimers and impaired apoptosis signaling (Price2014Natural). Clinical manifestations of ALPS include chronic multilineage cytopenias and an increased risk of B-cell lymphoma (Price2014Natural).

The clinical penetrance of FAS mutations is variable, with less than 60% of individuals with a mutation exhibiting symptoms of ALPS. This variability influences genetic counseling and medical management decisions (Price2014Natural). Understanding the molecular consequences of FAS mutations is crucial for predicting their impact and managing associated conditions (Hsu2012Autoimmune).

## Interactions
The FAS gene encodes the Fas cell surface death receptor, which plays a pivotal role in apoptosis through its interactions with various proteins. Fas interacts with the Fas-associated death domain (FADD) protein, a crucial component in the formation of the death-inducing signaling complex (DISC). This interaction is mediated by the death domains present in both Fas and FADD, facilitating the recruitment of procaspase-8 to the DISC, which initiates the apoptotic cascade (Mahdizadeh2021Reconstruction; Chinnaiyan1995FADD).

Fas also interacts with FAP-1, a protein tyrosine phosphatase, through its cytosolic domain. This interaction involves the last 15 amino acids of Fas and the GLGF3 domain of FAP-1, potentially inhibiting Fas-mediated apoptotic signals (Sato1995FAP1:). The interaction between Fas and FAP-1 suggests a regulatory mechanism where FAP-1 may modulate Fas signal transduction, particularly in tissues resistant to Fas-mediated cytotoxicity (Sato1995FAP1:).

Additionally, Fas forms homotrimeric complexes that are essential for the recruitment of FADD and the subsequent formation of the DISC. This process involves significant conformational changes in the Fas death domain, which are crucial for its function in apoptosis (Mahdizadeh2021Reconstruction).


## References


[1. (Mahdizadeh2021Reconstruction) Sayyed Jalil Mahdizadeh, Melissa Thomas, and Leif A. Eriksson. Reconstruction of the fas-based death-inducing signaling complex (disc) using a protein–protein docking meta-approach. Journal of Chemical Information and Modeling, 61(7):3543–3558, July 2021. URL: http://dx.doi.org/10.1021/acs.jcim.1c00301, doi:10.1021/acs.jcim.1c00301. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/acs.jcim.1c00301)

[2. (Chinnaiyan1995FADD) Arul M. Chinnaiyan, Karen O’Rourke, Muneesh Tewari, and Vishva M. Dixit. Fadd, a novel death domain-containing protein, interacts with the death domain of fas and initiates apoptosis. Cell, 81(4):505–512, May 1995. URL: http://dx.doi.org/10.1016/0092-8674(95)90071-3, doi:10.1016/0092-8674(95)90071-3. This article has 1839 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/0092-8674(95)90071-3)

[3. (Lynch1995Fas) David H. Lynch, Fred Ramsdell, and Mark R. Alderson. Fas and fasl in the homeostatic regulation of immune responses. Immunology Today, 16(12):569–574, December 1995. URL: http://dx.doi.org/10.1016/0167-5699(95)80079-4, doi:10.1016/0167-5699(95)80079-4. This article has 432 citations.](https://doi.org/10.1016/0167-5699(95)80079-4)

[4. (Price2014Natural) Susan Price, Pamela A. Shaw, Amy Seitz, Gyan Joshi, Joie Davis, Julie E. Niemela, Katie Perkins, Ronald L. Hornung, Les Folio, Philip S. Rosenberg, Jennifer M. Puck, Amy P. Hsu, Bernice Lo, Stefania Pittaluga, Elaine S. Jaffe, Thomas A. Fleisher, V. Koneti Rao, and Michael J. Lenardo. Natural history of autoimmune lymphoproliferative syndrome associated with fas gene mutations. Blood, 123(13):1989–1999, March 2014. URL: http://dx.doi.org/10.1182/blood-2013-10-535393, doi:10.1182/blood-2013-10-535393. This article has 187 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1182/blood-2013-10-535393)

[5. (Strasser2009The) Andreas Strasser, Philipp J. Jost, and Shigekazu Nagata. The many roles of fas receptor signaling in the immune system. Immunity, 30(2):180–192, February 2009. URL: http://dx.doi.org/10.1016/j.immuni.2009.01.001, doi:10.1016/j.immuni.2009.01.001. This article has 722 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.immuni.2009.01.001)

[6. (Hsu2012Autoimmune) Amy P. Hsu, Kennichi C. Dowdell, Joie Davis, Julie E. Niemela, Stacie M. Anderson, Pamela A. Shaw, V. Koneti Rao, and Jennifer M. Puck. Autoimmune lymphoproliferative syndrome due to fas mutations outside the signal-transducing death domain: molecular mechanisms and clinical penetrance. Genetics in Medicine, 14(1):81–89, January 2012. URL: http://dx.doi.org/10.1038/gim.0b013e3182310b7d, doi:10.1038/gim.0b013e3182310b7d. This article has 40 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/gim.0b013e3182310b7d)

[7. (Sato1995FAP1:) Takaaki Sato, Shinji Irie, Shinichi Kitada, and John C. Reed. Fap-1: a protein tyrosine phosphatase that associates with fas. Science, 268(5209):411–415, April 1995. URL: http://dx.doi.org/10.1126/science.7536343, doi:10.1126/science.7536343. This article has 518 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1126/science.7536343)

[8. (Alderson1993Fas) M R Alderson, R J Armitage, E Maraskovsky, T W Tough, E Roux, K Schooley, F Ramsdell, and D H Lynch. Fas transduces activation signals in normal human t lymphocytes. The Journal of experimental medicine, 178(6):2231–2235, December 1993. URL: http://dx.doi.org/10.1084/jem.178.6.2231, doi:10.1084/jem.178.6.2231. This article has 398 citations.](https://doi.org/10.1084/jem.178.6.2231)